Manufacturer:Pfizer Injectables (Hospira)
minimise freeze-thaw cycles
A peer-reviewed study in the Journal of Endocrinology confirming that AOD9604 produces lipolysis and increases fat oxidation in obese mice via the beta-adrenergic pathway, with effects comparable to full-length HGH but without the insulin-disrupting side effects provided early mechanistic validation that informed the human trials
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing
Some antibiotics are not suitable for women who are pregnant or breastfeeding, or people with certain medical conditions
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)